| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | Director | Common Stock | 10,000 | $58,383 | $5.84 | 24 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | 24 Mar 2025 | 1 | +$58,383 | 4 | Director | 25 Mar 2025, 18:32 |
| GLUE | Monte Rosa Therapeutics, Inc. | 23 Jun 2021 | 1 | $0 | 4 | Director | 25 Jun 2021, 17:01 |
| GLUE | Monte Rosa Therapeutics, Inc. | 23 Jun 2021 | 0 | $0 | 3 | Director | 23 Jun 2021, 20:46 |